ACW 4.17% 4.6¢ actinogen medical limited

Ann: Ethics Approval Granted for Second Phase 1 Study of Xanamem

  1. lightbulb Created with Sketch. 851
    • Release Date: 16/02/15 09:37
    • Summary: Ethics Approval Granted for Second Phase 1 Study of Xanamem
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
-0.00(4.17%)
Mkt cap $51.42M
Open High Low Value Volume
4.6¢ 4.6¢ 4.5¢ $84.90K 1.861M

Buyers (Bids)

No. Vol. Price($)
2 718606 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 29783 1
Last update - 16.10pm 17/12/2018 (20 minute delay) ?
(live)
Last
4.6¢
  Change
-0.00 ( 2.13 %)
Open High   Low Volume
4.6¢ 4.6¢   4.5¢ 213353
Last updated 15.15pm 17/12/2018 (live) ?
ACW (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.